ProPhase Labs (PRPH)
(Delayed Data from NSDQ)
$2.69 USD
+0.29 (12.08%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $2.69 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth A Momentum F VGM
Cash flow Statements
Fiscal Year End for ProPhase Labs, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -16.78 | 18.46 | 6.27 | -2.13 | -3.15 |
Depreciation/Amortization & Depletion | 6.83 | 5.07 | 3.57 | 0.46 | 0.40 |
Net Change from Assets/Liabilities | -5.70 | -3.65 | -34.62 | -0.61 | 1.11 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | -0.20 | 0.04 |
Other Operating Activities | 4.30 | 8.67 | 11.16 | -0.12 | 0.76 |
Net Cash From Operating Activities | -11.35 | 28.55 | -13.62 | -2.59 | -0.84 |
Property & Equipment | -3.11 | -3.92 | -4.23 | 0.39 | -0.23 |
Acquisition/ Disposition of Subsidiaries | -2.43 | 0.00 | -9.07 | -2.50 | 0.00 |
Investments | 4.17 | 1.39 | -5.67 | -0.72 | 5.77 |
Other Investing Activities | 0.00 | 0.45 | -0.70 | 1.81 | 0.00 |
Net Cash from Investing Activities | -1.37 | -2.08 | -19.67 | -1.02 | 5.54 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | -4.77 | -9.63 | 39.72 | 0.00 | 0.00 |
Issuance (Repayment) of Debt | 10.52 | -7.04 | -0.05 | 10.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | -9.35 | -4.55 | 0.00 | -5.82 |
Other Financing Activities | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 |
Net Cash from Financing Activities | 5.76 | -26.02 | 35.13 | 9.99 | -5.82 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -6.96 | 0.45 | 1.84 | 6.38 | -1.12 |
Cash at Beginning of Period | 9.11 | 8.66 | 6.82 | 0.43 | 1.55 |
Cash at End of Period | 2.15 | 9.11 | 8.66 | 6.82 | 0.43 |
Diluted Net EPS | -0.98 | 1.02 | 0.40 | -0.18 | -0.27 |
Fiscal Year End for ProPhase Labs, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -12.42 | -6.27 | -16.78 | -8.03 | -2.89 |
Depreciation/Amortization & Depletion | 3.91 | 1.94 | 6.83 | 4.86 | 2.90 |
Net Change from Assets/Liabilities | -3.73 | 0.28 | -5.70 | -7.26 | -9.13 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 2.31 | -1.07 | 4.30 | -0.70 | 2.64 |
Net Cash From Operating Activities | -9.94 | -5.12 | -11.35 | -11.14 | -6.48 |
Property & Equipment | -0.81 | -0.94 | -3.11 | -1.85 | -1.18 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | -2.43 | -2.43 | -2.43 |
Investments | 3.37 | 3.37 | 4.17 | 4.17 | 3.17 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 2.56 | 2.44 | -1.37 | -0.11 | -0.44 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 4.62 | 0.00 | -4.77 | -4.77 | -5.97 |
Issuance (Repayment) of Debt | 2.97 | 2.27 | 10.52 | 7.60 | 7.60 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | 7.59 | 2.27 | 5.76 | 2.83 | 1.63 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | 0.22 | -0.41 | -6.96 | -8.41 | -5.29 |
Cash at Beginning of Period | 2.15 | 2.15 | 9.11 | 9.11 | 9.11 |
Cash at End of Period | 2.37 | 1.74 | 2.15 | 0.70 | 3.82 |
Diluted Net EPS | -0.33 | -0.35 | -0.51 | -0.30 | -0.20 |